1172 related articles for article (PubMed ID: 16146805)
1. Cyclins and CDKS in development and cancer: lessons from genetically modified mice.
Santamaria D; Ortega S
Front Biosci; 2006 Jan; 11():1164-88. PubMed ID: 16146805
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
[TBL] [Abstract][Full Text] [Related]
3. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip).
Chen WJ; Chang CY; Lin JK
Biochem Pharmacol; 2003 Jun; 65(11):1777-85. PubMed ID: 12781329
[TBL] [Abstract][Full Text] [Related]
4. Characterization of murine gammaherpesvirus 68 v-cyclin interactions with cellular cdks.
Upton JW; van Dyk LF; Speck SH
Virology; 2005 Oct; 341(2):271-83. PubMed ID: 16102793
[TBL] [Abstract][Full Text] [Related]
5. p27kip1 Regulates cdk2 activity in the proliferating zone of the mouse intestinal epithelium: potential role in neoplasia.
Smartt HJ; Guilmeau S; Nasser SV; Nicholas C; Bancroft L; Simpson SA; Yeh N; Yang W; Mariadason JM; Koff A; Augenlicht LH
Gastroenterology; 2007 Jul; 133(1):232-43. PubMed ID: 17631145
[TBL] [Abstract][Full Text] [Related]
6. S-Phase entry upon ectopic expression of G1 cyclin-dependent kinases in the absence of retinoblastoma protein phosphorylation.
Leng X; Connell-Crowley L; Goodrich D; Harper JW
Curr Biol; 1997 Sep; 7(9):709-12. PubMed ID: 9285720
[TBL] [Abstract][Full Text] [Related]
7. Control of G1 progression by D-type cyclins: key event for cell proliferation.
Kato JY
Leukemia; 1997 Apr; 11 Suppl 3():347-51. PubMed ID: 9209386
[TBL] [Abstract][Full Text] [Related]
8. Differential modulation of G1-S-phase cyclin-dependent kinase 2/cyclin complexes occurs during the acquisition of a polyploid DNA content.
Datta NS; Williams JL; Long MW
Cell Growth Differ; 1998 Aug; 9(8):639-50. PubMed ID: 9716181
[TBL] [Abstract][Full Text] [Related]
9. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes.
Nahum A; Hirsch K; Danilenko M; Watts CK; Prall OW; Levy J; Sharoni Y
Oncogene; 2001 Jun; 20(26):3428-36. PubMed ID: 11423993
[TBL] [Abstract][Full Text] [Related]
10. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
[TBL] [Abstract][Full Text] [Related]
11. Doenjang hexane fraction-induced G1 arrest is associated with the inhibition of pRB phosphorylation and induction of Cdk inhibitor p21 in human breast carcinoma MCF-7 cells.
Choi YH; Choi BT; Lee WH; Rhee SH; Park KY
Oncol Rep; 2001; 8(5):1091-6. PubMed ID: 11496322
[TBL] [Abstract][Full Text] [Related]
12. Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF-beta.
Ravitz MJ; Wenner CE
Adv Cancer Res; 1997; 71():165-207. PubMed ID: 9111866
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of selected cell cycle regulatory proteins during aerobic and hypoxic maintenance of human ovarian carcinoma cells.
Krtolica A; Krucher NA; Ludlow JW
Br J Cancer; 1999 Aug; 80(12):1875-83. PubMed ID: 10471034
[TBL] [Abstract][Full Text] [Related]
14. Animal Models for Studying the In Vivo Functions of Cell Cycle CDKs.
Risal S; Adhikari D; Liu K
Methods Mol Biol; 2016; 1336():155-66. PubMed ID: 26231715
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated gene transfer of MMAC1/PTEN to glioblastoma cells inhibits S phase entry by the recruitment of p27Kip1 into cyclin E/CDK2 complexes.
Cheney IW; Neuteboom ST; Vaillancourt MT; Ramachandra M; Bookstein R
Cancer Res; 1999 May; 59(10):2318-23. PubMed ID: 10344736
[TBL] [Abstract][Full Text] [Related]
16. Revisiting the "Cdk-centric" view of the mammalian cell cycle.
Malumbres M
Cell Cycle; 2005 Feb; 4(2):206-10. PubMed ID: 15655365
[TBL] [Abstract][Full Text] [Related]
17. Differential control of cyclins D1 and D3 and the cdk inhibitor p27Kip1 by diverse signalling pathways in Swiss 3T3 cells.
Mann DJ; Higgins T; Jones NC; Rozengurt E
Oncogene; 1997 Apr; 14(15):1759-66. PubMed ID: 9150381
[TBL] [Abstract][Full Text] [Related]
18. Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms.
Satyanarayana A; Kaldis P
Oncogene; 2009 Aug; 28(33):2925-39. PubMed ID: 19561645
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
20. p21 is a critical CDK2 regulator essential for proliferation control in Rb-deficient cells.
Brugarolas J; Bronson RT; Jacks T
J Cell Biol; 1998 Apr; 141(2):503-14. PubMed ID: 9548727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
